Tango Therapeutics, Inc.
TNGXCIK 0001819133 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K filed Mar 5, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0122Δ+0.000592% similar+409/-368 ¶
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Tango Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Mva Investors, LLC | Director | 8 |
| Beckman Daniella | Officer | 7 |
| Weber Barbara | OfficerDirector | 7 |
| Barry Douglas | Officer | 6 |
| Peters Malte | OfficerDirector | 6 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Tango Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Barry Douglas | 4 | 100% | +48.0% | +45.8% | +62.4% | +38.0% |
| 2 | Boxer Capital Management, LLC | 4 | 100% | +41.3% | +51.1% | +56.9% | +6.2% |
| 3 | Boxer Asset Management Inc. | 7 | 100% | +31.4% | +37.8% | +62.0% | +4.1% |
| 4 | Boxer Capital, LLC | 7 | 100% | +31.4% | +37.8% | +62.0% | +4.1% |
| 5 | Lewis Joseph | 7 | 100% | +31.4% | +37.8% | +62.0% | +4.1% |
| 6 | Trv Gp IV, LLC | 24 | 71% | +22.7% | +33.8% | +72.9% | -66.1% |
| 7 | Third Rock Ventures Gp IV, L.P. | 24 | 71% | +22.7% | +33.8% | +72.9% | -66.1% |
| 8 | Third Rock Ventures IV, L.P. | 24 | 71% | +22.7% | +33.8% | +72.9% | -66.1% |
| 9 | Davis Aaron I. | 19 | 74% | +11.1% | +11.9% | +62.0% | -69.3% |
| 10 | Beckman Daniella | 6 | 67% | +5.0% | +38.2% | +62.4% | -81.0% |
All filings
96 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|